KARO BIO AND ZYDUS CADILA SIGN RESEARCH AGREEMENT FOR DEVELOPMENT OF NOVEL DRUGS TO TREAT INFLAMMATORY DISEASES
Karo Bio and Zydus Cadila, one of India’s leading healthcare companies, have initiated a three year research collaboration with the purpose to discover and develop novel, selective glucocorticoid receptor (GR) modulators for the treatment of inflammatory diseases.Glucocorticoids are used to treat many different inflammatory conditions such as rheumatoid arthritis, inflammatory bowels disease, psoriasis and asthma which together represent a market potential of over USD 10 bn. These powerful anti-inflammatory agents with long term use could, however, lead to the development of unwanted side